Today: Weekly Analysts’ Ratings Changes for Celldex Therapeutics (CLDX)

Today: Weekly Analysts’ Ratings Changes for Celldex Therapeutics (CLDX)

Celldex Therapeutics (NASDAQ: CLDX) recently received a number of ratings updates from brokerages and research firms:

Celldex Therapeutics Inc. (NASDAQ:CLDX) opened at 4.43 on Monday. Celldex Therapeutics Inc. has a 12-month low of $2.85 and a 12-month high of $18.56. The stock has a 50 day moving average of $3.78 and a 200 day moving average of $4.09. The company’s market capitalization is $448.53 million.

Related posts

Leave a Comment